Insider · CIK 0000901877
Philippe Benacin
Files at IPAR (INTER PARFUMS INC). First filing Mar 5, 2024, latest Dec 12, 2025.
In brief
Philippe Benacin files SEC Form 4 as president, director and 10% owner at IPAR (INTER PARFUMS INC). Since Mar 5, 2024, Philippe Benacin has reported 0 open-market buys worth $0 and 3 open-market sells worth $8.6M, the latest filed on Dec 12, 2025.
A track record needs three past buys with six months of prices behind them; Philippe Benacin has 0, so none is measured yet.
The newest scored trade: sold $2.1M of IPAR on Dec 11, 2025, filed Dec 12, 2025, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $2.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IPAR: INTER PARFUMS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | IPARsell INTER PARFUMS INC | $2.1M 25,000 shares | -0% | +4% from low-42% from high | |
| 45Moderate | IPARsell INTER PARFUMS INC | $2.9M 25,000 shares | -0% | - | |
| 53Moderate | INTER PARFUMS INC | $3.5M 25,000 shares | -0% | +16% from low-10% from high |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | IPAR INTER PARFUMS INC | MOption exercise Common Stockindirect: By personal holding company | +25,000 | $73.09 | $1.8M | 6,871,064 | Dec 12, 2025 |
| Dec 11, 2025 | IPAR INTER PARFUMS INC | SOpen-market sale Common Stockindirect: By personal holding company | -25,000 | $83.24 | $2.1M | 6,846,064 | Dec 12, 2025 |
| Dec 11, 2025 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 11, 2025 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 11, 2025 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 11, 2025 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 11, 2025 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Mar 21, 2025 | IPAR INTER PARFUMS INC | SOpen-market sale Common Stockindirect: By personal holding company | -25,000 | $117.38 | $2.9M | 6,846,064 | Mar 24, 2025 |
| Dec 18, 2024 | IPAR INTER PARFUMS INC | MOption exercise Common Stockindirect: By personal holding company | +25,000 | $65.25 | $1.6M | 6,871,064 | Dec 18, 2024 |
| Dec 18, 2024 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 18, 2024 |
| Dec 18, 2024 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 18, 2024 |
| Dec 18, 2024 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 18, 2024 |
| Dec 18, 2024 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 18, 2024 |
| Dec 18, 2024 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 18, 2024 |
| Mar 4, 2024 | IPAR INTER PARFUMS INC | SOpen-market sale Common Stockindirect: By personal holding company | -25,000 | $141.77 | $3.5M | 6,846,064 | Mar 5, 2024 |
| Dec 28, 2023 | IPAR INTER PARFUMS INC | MOption exercise Common Stockindirect: By personal holding company | +25,000 | $43.80 | $1.1M | 6,871,064 | Dec 29, 2023 |
| Dec 28, 2023 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 29, 2023 |
| Dec 28, 2023 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 29, 2023 |
| Dec 28, 2023 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 29, 2023 |
| Dec 28, 2023 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 29, 2023 |
| Dec 28, 2023 | IPAR INTER PARFUMS INC | MOption exercise Option-right to buyderivativeindirect: by personal holding company | -5,000 | $0.00 | $0 | 0 | Dec 29, 2023 |
Questions about Philippe Benacin
Answered from the filings on this page, as of the latest one.
Is Philippe Benacin buying or selling?
In the last 12 months Philippe Benacin reported 0 open-market buys worth $0 and 1 open-market sell worth $2.1M on SEC Form 4; the latest was sold $2.1M of IPAR on Dec 11, 2025. Grants, option exercises and tax withholding are not counted.
How did Philippe Benacin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Philippe Benacin has 0.
Where does Philippe Benacin file Form 4?
Philippe Benacin has filed Form 4 at IPAR (INTER PARFUMS INC) as President Interparfums SA. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.